Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BF Suma Pharmaceuticals develops and manufactures a broad portfolio of dietary supplements and functional foods with commercial distribution in over fifteen countries. Their product lines include anti-aging NMN series, probiotics sachets for digestive health, cardiovascular support supplements like Coenzyme Q10 capsules and Detoxilive soft gels, as well as skin care products. The company operates cGMP-certified manufacturing facilities in the US and Hong Kong. No clinical trial data or prescription drug development was identified; all products are marketed as dietary supplements or functional foods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BF Suma Pharmaceuticals.